MedTrace Logo

Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans' Perceptions/Beliefs About COVID-19 Testing and Vaccination Study

NCT04964154 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4000

Last updated 2021-07-15

No results posted yet for this study

Summary

The Building Resilience and Vital Equity (BRAVE) project seeks to partner with American Indian tribal communities in North Carolina to establish COVID-19 services and resources for American Indian communities. The goal of this study is to 1) understand the barriers and social implications of COVID19 testing and vaccination among American Indians by designing and implementing culturally sensitive survey tools and intervention materials; 2) Implement BRAVE outreach and testing interventions to increase testing in American Indian communities; 3) analyze data and share back with tribal communities to improve perceptions of COVID-19 testing in the AI community and decrease in vaccine hesitancy.

Conditions

  • Covid19 Virus Infection

Interventions

BEHAVIORAL

Protect Your Elders Campaign

This is a behavioral intervention where participants will receive cultural appropriate educational information about COVID-19 testing and vaccination.

Sponsors & Collaborators

  • Lumbee Tribe of North Carolina

    collaborator UNKNOWN

  • University of North Carolina at Pembroke

    collaborator UNKNOWN

  • North Carolina Central University

    lead OTHER

Principal Investigators

  • Deepak Kumar, PhD · North Carolina Central University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-17
Primary Completion
2022-03-30
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04964154 on ClinicalTrials.gov